Study of an injectable in situ forming gel for sustained-release of Ivermectin in vitro and in vivo

International Journal of Biological Macromolecules

Volumn 85, Issue , 2016, Pages 271-276

  Geng, Zhixia ^a,b   Luo, Xiaoqing ^a   Zhang, Zhenrui ^a   Li, Huimin ^a   Tian, Jing ^a   Yu, Zugong ^a  

^a NANJING AGRICULTURAL UNIVERSITY   (China)

^b HeBei Yuanzheng Pharmaceutical Co   (China)

Author keywords

Dog; In situ forming gel; Ivermectin; Pharmacokinetic; Sustained release

Indexed keywords

IVERMECTIN; ANTIPARASITIC AGENT; DELAYED RELEASE FORMULATION; GEL; SOLVENT;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; EXTENDED RELEASE TIME; GEL; IN VITRO STUDY; IN VIVO STUDY; MAXIMUM PLASMA CONCENTRATION; MEDICAL PARAMETERS; NONHUMAN; PHYSICAL CHEMISTRY; PRESCRIPTION; SOLVENT EFFECT; SUSTAINED RELEASE FORMULATION; SUSTAINED RELEASE PREPARATION; ANIMAL; CHEMISTRY; DELAYED RELEASE FORMULATION; DOG; DRUG RELEASE; PH; VISCOSITY;

ANIMALS; ANTIPARASITIC AGENTS; DELAYED-ACTION PREPARATIONS; DOGS; DRUG LIBERATION; GELS; HYDROGEN-ION CONCENTRATION; IVERMECTIN; SOLVENTS; VISCOSITY;

EID: 84953313050     PISSN: 01418130     EISSN: 18790003     Source Type: Journal    
DOI: 10.1016/j.ijbiomac.2015.12.028     Document Type: Article

References (47)

1. Ahn H.H., Kim K.S., Lee J.H., Lee J.Y., Kim B.S., Lee I.W., Chun H.J., Kim J.H., Lee H.B., Kim M.S. In vivo osteogenic differentiation of human adipose-derived stem cells in an injectable in situ-forming gel scaffold. Tissue Eng. Part A 2009, 15:1821-1832.
2. Astaneh R., Erfan M., Moghimi H., Mobedi H. Changes in morphology of in situ forming PLGA implant prepared by different polymer molecular weight and its effect on release behavior. J. Pharm. Sci. 2009, 98:135-145.
3. P.J. Burns, J.W. Gibson, A.J. Tipton, Compositions suitable for controlled release of the hormone GnRH and its analogs, CA (1997).
4. Büyüktimkin B., Wang Q., Kiptoo P., et al. Vaccine-like controlled-release delivery of an immunomodulating peptide to treat experimental autoimmune encephalomyelitis. Mol. Pharm. 2012, 9:979-985.
5. Camargo J.A., Sapin A., Nouvel C., Daloz D., Leonard M., Bonneaux F., Six J.L., Maincent P. Injectable PLA-based in situ forming implants for controlled release of Ivermectin a BCS Class II drug: solvent selection based on physico-chemical characterization. Drug Dev. Ind. Pharm. 2013, 39:146-155.
6. Campbell W.C., Fisher M.H., Stapley E.O., Albers-Schonberg G., Jacob T.A. Ivermectin: a potent new antiparasitic agent. Science 1983, 221:823-828.
7. Chittrakarn S., Janchawee B., Ruangrut P., Kansenalak S., Chethanond U., Kobasa T., Thammapalo S. Pharmacokinetics of Ivermectin in cats receiving a single subcutaneous dose. Res. Vet. Sci. 2009, 86:503-507.
8. Cho K.Y., Lee S., Park J.K. In situ micro-sized gel-forming injectable implant using biodegradable amphiphilic graft copolymer. Macromol. Biosci. 2007, 7:784-788.
9. Clark S.L., Crowley A.J., Schmidt P.G., Donoghue A.R., Piché C.A. Long-term delivery of Ivermectin by use of poly(d,l-lactic-co-glycolic) acid microparticles in dogs. Am. J. Vet. Res. 2005, 65:752-757.
10. Eliaz R.E., Wallach D., Kost J. Delivery of soluble tumor necrosis factor receptor from in-situ forming PLGA implants: in-vivo. Pharm. Res. 2000, 17:1546-1550.
11. Ganguly S., Dash A.K. A novel in situ gel for sustained drug delivery and targeting. Int. J. Pharm. 2004, 276:83-92.
12. Gao Z., Ding P., Zhang L., Shi J., Yuan S., Wei J., Chen D. Study of a pingyangmycin delivery system: Zein/Zein-SAIB in situ gels. Int. J. Pharm. 2007, 328:57-64.
13. Geary T.G. Ivermectin 20 years on: maturation of a wonder drug. Trends Parasitol. 2005, 21:530-532.
14. Geary T.G., Sims S.M., Thomas E.M., Vanover L., Davis J.P., Winterrowd C.A., Klein R.D., Ho N.F., Thompson D.P. Haemonchus contortus: Ivermectin-induced paralysis of the pharynx. Exp. Parasitol. 1993, 77:88-96.
15. Ghahremankhani A.A., Dorkoosh F., Dinarvand R. PLGA-PEG-PLGA tri-block copolymers as in situ gel-forming peptide delivery system: effect of formulation properties on peptide release. Pharm. Dev. Technol. 2008, 13:49-55.
16. Gill J.H., Lacey E. Avermectin/milbemycin resistance in trichostrongyloid nematodes. Int. J. Parasitol. 1998, 28:863-877.
17. Hu C., Feng H., Zhu C. Preparation and characterization of rifampicin-PLGA microspheres/sodium alginate in situ gel combination delivery system. Coll. Surf. B: Biointerfaces 2012, 95:162-169.
18. Huang X., Brazel C.S. On the importance and mechanisms of burst release in matrix-controlled drug delivery systems. J. Controll. Release 2001, 73:121-136.
19. Kempe S., Mader K. In situ forming implants - an attractive formulation principle for parenteral depot formulations. J. Controll. Release 2012, 161:668-679.
20. Kempe S., Metz H., Pereira P.G., Mader K. Non-invasive in vivo evaluation of in situ forming PLGA implants by benchtop magnetic resonance imaging (BT-MRI) and EPR spectroscopy. Eur. J. Pharm. Biopharm. 2010, 74:102-108.
21. Khodaverdi E., Tekie F.S., Mohajeri S.A., Ganji F., Zohuri G., Hadizadeh F. Preparation and investigation of sustained drug delivery systems using an injectable, thermosensitive, in situ forming hydrogel composed of PLGA-PEG-PLGA. AAPS PharmSciTech 2012, 13:590-600.
22. Korber M., Bodmeier R. Development of an in situ forming PLGA drug delivery system I. Characterization of a non-aqueous protein precipitation. Eur. J. Pharm. Sci. 2008, 35:283-292.
23. Kraeling R.R., Barb C.R., Rampacek G.B., Thompson D.L., Gibson J.W., Sullivan S.A., Simon B., Burns P.J. Luteinizing hormone response to controlled-release deslorelin in estradiol benzoate primed ovariectomized gilts. Theriogenology 2000, 53:1681-1689.
24. Kranz H., Yilmaz E., Brazeau G.A., Bodmeier R. In vitro and in vivo drug release from a novel in situ forming drug delivery system. Pharm. Res. 2008, 25:1347-1354.
25. Krishna D.R., Klotz U. Determination of ivermectin in human plasma by high-performance liquid chromatography. Arzneimittel-Forschung 1993, 43:609-611.
26. Krishna G., Sheth B.B. A novel self emulsifying parenteral drug delivery system. PDA J. Pharm. Sci. Technol. 1999, 53:168-176.
27. Lee J.Y., Kim K.S., Kang Y.M., Kim E.S., Hwang S.J., Lee H.B., Min B.H., Kim J.H., Kim M.S. In vivo efficacy of paclitaxel-loaded injectable in situ-forming gel against subcutaneous tumor growth. Int. J. Pharm. 2010, 392:51-56.
28. Li F., Liu Y., Ding Y., Xie Q. A new injectable in situ forming hydroxyapatite and thermosensitive chitosan gel promoted by Na(2)CO(3). Soft Matter 2014, 10:2292-2303.
29. Lifschitz A., Virkel G., Ballent M., Sallovitz J., Imperiale F., Pis A., Lanusse C. Ivermectin (3.15%) long-acting formulations in cattle: absorption pattern and pharmacokinetic considerations. Vet. Parasitol. 2007, 147:303-310.
30. Lifschitz A., Virkel G., Pis A., Imperiale F., Sanchez S., Alvarez L., et al. Ivermectin disposition kinetics after subcutaneous and intramuscular administration of an oil-based formulation to cattle. Vet. Parasitol. 1999, 86:203-215.
31. Lin X., Yang S., Gou J., Zhao M., Zhang Y., Qi N., He H., Cai C., Tang X., Guo P. A novel risperidone-loaded SAIB-PLGA mixture matrix depot with a reduced burst release: effects of solvents and PLGA on drug release behaviors in vitro/in vivo. J. Mater. Sci.: Mater. Med. 2012, 23:443-455.
32. Lu Y., Yu Y., Tang X. Sucrose acetate isobutyrate as an in situ forming system for sustained risperidone release. J. Pharm. Sci. 2007, 96:3252-3262.
33. Mashayekhi R., Mobedi H., Najafi J., Enayati M. In-vitro/In-vivo comparison of leuprolide acetate release from an in-situ forming plga system. Daru: J. Fac. Pharm. 2013, 21:57. Tehran University of Medical Sciences.
34. Nagarwal R.C., Kumar R., Dhanawat M., Pandit J.K. Modified PLA nano in situ gel: a potential ophthalmic drug delivery system. Coll. Surf. B: Biointerfaces 2011, 86:28-34.
35. Okumu F.W., Dao le N., Fielder P.J., Dybdal N., Brooks D., Sane S., Cleland J.L. Sustained delivery of human growth hormone from a novel gel system: SABER. Biomaterials 2002, 23:4353-4358.
36. Paavola A., Yliruusi J., Rosenberg P. Controlled release and dura mater permeability of lidocaine and ibuprofen from injectable poloxamer-based gels. J. Controll. Release 1998, 52:169-178.
37. Qin Y., Yuan M., Li L., Li W., Xue J. Formulation and evaluation of in situ forming PLA implant containing tinidazole for the treatment of periodontitis. J. Biomed. Mater. Res. 2012, 100:2197-2220. Part B Applied biomaterials.
38. Schadlich A., Kempe S., Mader K. Non-invasive in vivo characterization of microclimate pH inside in situ forming PLGA implants using multispectral fluorescence imaging. J. Controll. Release 2014, 179:52-62.
39. Schoenhammer K., Petersen H., Guethlein F., Goepferich A. Injectable in situ forming depot systems: PEG-DAE as novel solvent for improved PLGA storage stability. Int. J. Pharm. 2009, 371:33-39.
40. Solorio L., Olear A.M., Hamilton J.I., Patel R.B., Beiswenger A.C., Wallace J.E., Zhou H., Exner A.A. Noninvasive characterization of the effect of varying PLGA molecular weight blends on in situ forming implant behavior using ultrasound imaging. Theranostics 2012, 2:1064-1077.
41. Song F., Li X., Wang Q., et al. Nanocomposite hydrogels and their applications in drug delivery and tissue engineering. J. Biomed. Nanotechnol. 2015, 11:40-52.
42. Strong L., James S. Some effects of ivermectin on the yellow dung fly, Scatophaga stercoraria. Vet. Parasitol. 1993, 48:181-191.
43. Voigt M., Koerber M., Bodmeier R. Improved physical stability and injectability of non-aqueous in situ PLGA microparticle forming emulsions. Int. J. Pharm. 2012, 434:251-256.
44. Wang Q., Gu Z., Jamal S., et al. Hybrid hydroxyapatite nanoparticle colloidal gels are injectable fillers for bone tissue engineering. Tissue Eng. Part A 2013, 19:2586-2593.
45. Wang Q., Jamal S., Detamore M.S., et al. PLGA-chitosan/PLGA-alginate nanoparticle blends as biodegradable colloidal gels for seeding human umbilical cord mesenchymal stem cells. J. Biomed. Mater. Res. A 2011, 96:520-527.
46. Wang Q., Wang J., Lu Q., et al. Injectable PLGA based colloidal gels for zero-order dexamethasone release in cranial defects. Biomaterials 2010, 31:4980-4986.
47. Zhong T., Deng C., Gao Y., Chen M., Zuo B. Studies of in situ-forming hydrogels by blending PLA-PEG-PLA copolymer with silk fibroin solution. J. Biomed. Mater. Res. Part A 2012, 100:1983-1989.